PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UW study: Sleep apnea associated with higher mortality from cancer

2012-05-21
(Press-News.org) Madison, Wis. and San Francisco — Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.

While previous studies have associated SDB with increased risks of hypertension, cardiovascular disease, depression, and early death, this is the first human study to link apnea with higher rate of cancer mortality. Lead author Dr. F. Javier Nieto, chair of the department of population health sciences at the UW School of Medicine and Public Health, says the study showed a nearly five times higher incidence of cancer deaths in patients with severe SDB compared to those without the disorder, a result that echoes previous findings in animal studies.

"Clearly, there is a correlation, and we are a long way from proving that sleep apnea causes cancer or contributes to its growth," says Nieto, an expert in sleep epidemiology. "But animal studies have shown that the intermittent hypoxia (an inadequate supply of oxygen) that characterizes sleep apnea promotes angiogenesis—increased vascular growth--and tumor growth. Our results suggest that SDB is also associated with an increased risk of cancer mortality in humans."

Dr. Nieto will present his study May 20 at the American Thoracic Society 2012 International Conference in San Francisco. It will be published in American Journal of Respiratory and Critical Care Medicine.

The team of University of Wisconsin-Madison investigators led by Nieto conducted this research in collaboration with Dr. Ramon Farré, professor of physiology at University of Barcelona, Spain. In a separate study also presented at the ATS conference, Dr. Farré's group showed that the effect of intermittent hypoxia on cancer growth is considerably stronger in lean mice than in obese mice.

The Wisconsin researchers examined 22-year mortality data on 1,522 subjects from the Wisconsin Sleep Cohort. This cohort is a longitudinal, community-based epidemiology study of sleep apnea and other sleep problems that begun in 1989 under the leadership of Dr. Terry Young, also a member of the UW population health sciences faculty. The cohort began was a random sample of Wisconsin state employees.

The participants undergo overnight sleep studies that include polysomnography – an all-night recording of sleep and breathing – and many other tests at four-year intervals. The studies are conducted in a specially designed unit at the federally funded UW Institute for Clinical and Transitional Research Center (ICTR).

After adjustment for age, sex, body mass index, and smoking, Nieto's study found that both all-cause and cancer mortality were associated with the presence and severity of SDB in a dose-response fashion. People with severe SDB died of cancer at a rate 4.8 times higher than people with no sleep breathing problems.

These associations were similar after excluding the 126 subjects who had used continuous positive airway pressure and were stronger among non-obese subjects than obese subjects.

"In our large population-based sample, SDB was associated with an elevated risk of cancer mortality," concluded Dr. Nieto. "Additional studies are needed to replicate these results. If the relationship between SDB and cancer mortality is validated in further studies, the diagnosis and treatment of SDB in patients with cancer might be indicated to prolong survival."

###

Members of the Wisconsin team include Dr. Paul Peppard, the principal investigator of the Wisconsin Sleep Cohort, Dr. Terry Young, Laurel Finn and Dr. K. Mae Hla.

END



ELSE PRESS RELEASES FROM THIS DATE:

First, do no harm: Study finds danger in standard treatment for a serious lung disease

First, do no harm: Study finds danger in standard treatment for a serious lung disease
2012-05-21
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to the surprising results of a rigorous independent study. The study, which will appear online May 20 in the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American Thoracic Society, was conducted by IPF Clinical Research Network, funded by the National Heart, Lung, and Blood Institute ...

Lab tests show arthritis drug effective against global parasite

2012-05-21
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world. Based on these results, the team has received Orphan Drug Status for the drug, known as auranofin, from the U.S. Food and Drug Administration, and has applied for approval to start clinical trials to treat both amebiasis and the parasite Giardia in humans. The findings, which showed that ...

Drug found for parasite that is major cause of death worldwide

Drug found for parasite that is major cause of death worldwide
2012-05-21
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year. Using a high-throughput screen for drugs developed by the research team, they discovered that auranofin – a drug approved by the US Food and Drug Administration 25 years ago for rheumatoid arthritis – is very effective ...

Study examines treatments for relieving breathing difficulties among patients with lung effusions

2012-05-21
Helen E. Davies, M.D., of the University Hospital of Wales, Cardiff, and colleagues compared the effectiveness of treatments to relieve breathing difficulties among patients with malignant pleural effusion (presence of fluid in the pleural cavity [space between the outside of the lungs and the inside wall of the chest cavity], as a complication of malignant disease). The treatments compared were chest tube drainage and talc slurry for pleurodesis (a procedure in which the pleural space is obliterated) vs. indwelling pleural catheters (IPCs). Malignant pleural effusion ...

Low-dose CT screening may benefit individuals at increased risk for lung cancer

2012-05-21
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write. "Renewed enthusiasm for lung screening arose with the advent of LDCT imaging, which is able to identify smaller nodules than can chest radiographs." For the review, ...

Study evaluates use of inhaled saline for young children with cystic fibrosis

2012-05-21
Margaret Rosenfeld, M.D., M.P.H., of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF). Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with CF, but its efficacy has not been evaluated in patients younger than 6 years. In the randomized trial, the active treatment group (n = 158) received 7 percent hypertonic saline and the control group (n = 163) received 0.9 percent isotonic saline, ...

Songbirds' learning hub in brain offers insight into motor control

2012-05-21
To learn its signature melody, the male songbird uses a trial-and-error process to mimic the song of its father, singing the tune over and over again, hundreds of times a day, making subtle changes in the pitch of the notes. For the male Bengalese finch, this rigorous training process begins around the age of 40 days and is completed about day 90, just as he becomes sexually mature and ready to use his song to woo females. To accomplish this feat, the finch's brain must receive and process large quantities of information about its performance and use that data to precisely ...

Scientists identify new target to battle rheumatoid arthritis

Scientists identify new target to battle rheumatoid arthritis
2012-05-21
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA. Rheumatoid arthritis, a systemic inflammatory autoimmune disease that can be crippling, impacts over a million adults in the United States. "We uncovered a novel mechanism by which the Notch pathway could contribute to RA, said Xiaoyu Hu, M.D., Ph.D., a ...

Flavia Del Monte Launches New Targeted Metabolic Workout Program, Curvalicious

Flavia Del Monte Launches New Targeted Metabolic Workout Program, Curvalicious
2012-05-21
Internationally recognized fitness enthusiast, Flavia Del Monte, has spent years helping women learn how their bodies work, proper nutrition for women and how to exercise in a way that benefits women. As the founder of Flavilicious Fitness she has been creating workout and nutrition programs specifically designed for the needs of women. Flavia Del Monte's newest workout and nutrition program, Curvalicious, is the first to target metabolic fat loss while increasing both Myogenic and Neurogenic muscle tone. Myogenic muscle tone is the residual tension in a muscle at rest. ...

Discovery of mechanisms predicting response to new treatments in colon cancer

2012-05-21
Barcelona, 20 May 2012. The Stem Cells and Cancer Research Group headed by Dr Héctor G. Palmer at the Vall d'Hebrón Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Muñoz´s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Científicas (IIB-CSIC-Madrid). Published today in Nature Medicine, this work identifies biomarkers ...

LAST 30 PRESS RELEASES:

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day

Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds

Bronze and Iron Age cultures in the Middle East were committed to wine production

Indian adolescents are mostly starting their periods at an earlier age than 25 years ago

Temporary medical centers in Gaza known as "Medical Points" (MPs) treat an average of 117 people daily with only about 7 staff per MP

Rates of alcohol-induced deaths among the general population nearly doubled from 1999 to 2024

PLOS One study: In adolescent lab animals exposed to cocaine, High-Intensity Interval Training boosts aversion to the drug

Scientists identify four ways our bodies respond to COVID-19 vaccines

Stronger together: A new fusion protein boosts cancer immunotherapy

Hidden brain waves as triggers for post-seizure wandering

Music training can help the brain focus

Researcher develop the first hydride ion prototype battery

MIT researchers find a more precise way to edit the genome

‘Teen’ pachycephalosaur butts into fossil record

Study finds cocoa extract supplement reduced key marker of inflammation and aging

Obesity treatment with bariatric surgery vs GLP-1 receptor agonists

Nicotinamide for skin cancer chemoprevention

Novel way to ‘rev up’ brown fat burns calories, limits obesity in mice

USC Stem Cell-led team makes major advance toward building a synthetic kidney

Delegation to Artificial Intelligence can increase dishonest behavior

Repeated head impacts cause early neuron loss and inflammation in young athletes

BU study of young athletes finds neurodegeneration might begin before CTEa

Dr. Carl Nathan wins David and Beatrix Hamburg Award

New microscope captures large, high-resolution images of curved samples in single snapshot

[Press-News.org] UW study: Sleep apnea associated with higher mortality from cancer